• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高龄急性心力衰竭住院患者的临床特征和转归:药物治疗指南依从性的重要性。

Clinical Characteristics and Outcomes in the Very Elderly Patients Hospitalized for Acute Heart Failure: Importance of Pharmacologic Guideline Adherence.

机构信息

Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Department of Medicine, National Yang-Ming University, Taipei, Taiwan.

出版信息

Sci Rep. 2018 Sep 24;8(1):14270. doi: 10.1038/s41598-018-32684-9.

DOI:10.1038/s41598-018-32684-9
PMID:30250052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6155282/
Abstract

The prognostic factors and pharmacological effects of the very elderly patients (aged ≥80 years) with acute heart failure (AHF) remain unclear. The study, therefore, investigated the prognostic impacts of the guideline-recommended pharmacological therapy in these patients. A cohort of 1297 very elderly patients [85.1 ± 4.0 years, 69.7% male, 32.6% heart failure with reduced left ventricular ejection fraction (LVEF), HFrEF], hospitalized for AHF, was studied. The percentage of the recommended prescription for HFrEF at discharge, including renin-angiotensin system inhibitors, β-blockers, and mineralocorticoid receptor antagonists, was calculated as guideline adherence indicator (GAI). Among the 1233 survivors at discharge, 495 subjects (40.1%) died during a mean follow-up of 27.1 ± 23.9 months. Mean GAIs in HFrEF and HFpEF were 70.6 ± 34.9% and 64.1 ± 35.9%, respectively. A higher GAI was associated with less overall mortality [hazard ratio and 95% confidence interval per-1SD: 0.781, 0.655-0.930] and cardiovascular death (0.718, 0.558-0.925), independent of age, gender, diabetes, hypertension, mean blood pressure, LVEF, eGFR, sodium, and NT-proBNP. A GAI of 100% was associated with a better survival in both HFrEF and HFpEF. A prescription of the three recommended medications for HFrEF to the very elderly AHF patients was associated with a better survival after discharge.

摘要

高龄(≥80 岁)急性心力衰竭(AHF)患者的预后因素和药理学效应仍不清楚。因此,本研究调查了指南推荐的药物治疗对这些患者的预后影响。研究纳入了 1297 例高龄(85.1±4.0 岁,69.7%为男性,32.6%为射血分数降低的心力衰竭,HFrEF)AHF 住院患者。出院时根据指南推荐处方计算出 HFrEF 推荐药物的使用比例(包括肾素-血管紧张素系统抑制剂、β受体阻滞剂和盐皮质激素受体拮抗剂)作为指南依从性指标(GAI)。在出院的 1233 例存活患者中,495 例(40.1%)在平均 27.1±23.9 个月的随访期间死亡。HFrEF 和 HFpEF 的平均 GAI 分别为 70.6±34.9%和 64.1±35.9%。较高的 GAI 与全因死亡率降低相关[每增加 1 个标准差的风险比和 95%置信区间:0.781,0.655-0.930]和心血管死亡率降低(0.718,0.558-0.925),与年龄、性别、糖尿病、高血压、平均血压、LVEF、eGFR、钠和 NT-proBNP 无关。GAI 为 100%时,在 HFrEF 和 HFpEF 中均与更好的生存相关。对于高龄 AHF 患者,HFrEF 三种推荐药物的处方与出院后更好的生存相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e1/6155282/ef0201ccefa3/41598_2018_32684_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e1/6155282/debef9ccd2b3/41598_2018_32684_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e1/6155282/9acdf2d6c874/41598_2018_32684_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e1/6155282/ef0201ccefa3/41598_2018_32684_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e1/6155282/debef9ccd2b3/41598_2018_32684_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e1/6155282/9acdf2d6c874/41598_2018_32684_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e1/6155282/ef0201ccefa3/41598_2018_32684_Fig3_HTML.jpg

相似文献

1
Clinical Characteristics and Outcomes in the Very Elderly Patients Hospitalized for Acute Heart Failure: Importance of Pharmacologic Guideline Adherence.高龄急性心力衰竭住院患者的临床特征和转归:药物治疗指南依从性的重要性。
Sci Rep. 2018 Sep 24;8(1):14270. doi: 10.1038/s41598-018-32684-9.
2
Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.医生的指南遵循与射血分数降低的心力衰竭门诊患者的更好预后相关:QUALIFY 国际注册研究。
Eur J Heart Fail. 2017 Nov;19(11):1414-1423. doi: 10.1002/ejhf.887. Epub 2017 Apr 30.
3
Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.在一项为期5年的随访回顾性研究中,老年患者中射血分数保留的心力衰竭比射血分数降低的心力衰竭具有更好的长期预后。
Int J Cardiol. 2017 Apr 1;232:86-92. doi: 10.1016/j.ijcard.2017.01.048. Epub 2017 Jan 5.
4
Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.左心室射血分数对急性心力衰竭后肾素-血管紧张素系统阻滞剂疗效的影响:来自 KCHF 注册研究。
PLoS One. 2020 Sep 14;15(9):e0239100. doi: 10.1371/journal.pone.0239100. eCollection 2020.
5
Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry.射血分数降低的心力衰竭指南与临床实践之间的差距:来自 TSOC-HFrEF 注册研究的结果。
J Chin Med Assoc. 2017 Dec;80(12):750-757. doi: 10.1016/j.jcma.2017.04.011. Epub 2017 Oct 9.
6
Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.出院前优化指南指导的药物治疗对射血分数降低的心力衰竭住院患者死亡率和心力衰竭再入院的影响。
Am J Cardiol. 2018 Apr 15;121(8):969-974. doi: 10.1016/j.amjcard.2018.01.006. Epub 2018 Feb 21.
7
Natural history of left ventricular ejection fraction in patients with heart failure.心力衰竭患者左心室射血分数的自然病程。
Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):680-6. doi: 10.1161/CIRCOUTCOMES.111.000045. Epub 2013 Oct 15.
8
Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.当代射血分数降低的慢性心力衰竭的药物治疗:CHECK-HF 注册研究。
JACC Heart Fail. 2019 Jan;7(1):13-21. doi: 10.1016/j.jchf.2018.10.010.
9
Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.心力衰竭住院后使用血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂进行出院治疗与更好的预后相关,而与左心室射血分数无关。
Intern Med J. 2019 Dec;49(12):1505-1513. doi: 10.1111/imj.14289.
10
N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).N 末端脑利钠肽前体指导心力衰竭伴射血分数保留患者的管理:充血性心力衰竭老年患者强化与标准药物治疗试验(TIME-CHF)的结果。
Eur J Heart Fail. 2013 Oct;15(10):1148-56. doi: 10.1093/eurjhf/hft076. Epub 2013 May 8.

引用本文的文献

1
Heart Failure in Older Patients: An Update.老年患者心力衰竭:最新进展
J Clin Med. 2025 Mar 14;14(6):1982. doi: 10.3390/jcm14061982.
2
Ejection fraction at hospital admission stratifies mortality risk in HFmrEF patients aged ≥ 70 years: a retrospective analysis from a tertiary university institution.入院时射血分数分层高龄(≥70 岁)HFmrEF 患者的死亡率:来自三级大学机构的回顾性分析。
Aging Clin Exp Res. 2023 Aug;35(8):1679-1693. doi: 10.1007/s40520-023-02454-3. Epub 2023 Jun 5.
3
Polypharmacy definition and prevalence in heart failure: a systematic review.

本文引用的文献

1
Prognostic Nutritional Index and the Risk of Mortality in Patients With Acute Heart Failure.急性心力衰竭患者的预后营养指数与死亡风险
J Am Heart Assoc. 2017 Jun 25;6(6):e004876. doi: 10.1161/JAHA.116.004876.
2
Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.在植入心脏复律除颤器之前使用指南指导的心力衰竭药物治疗。
J Am Coll Cardiol. 2016 Mar 8;67(9):1062-1069. doi: 10.1016/j.jacc.2015.12.046.
3
Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review.
心力衰竭中药物滥用的定义和流行率:系统评价。
Heart Fail Rev. 2022 Mar;27(2):465-492. doi: 10.1007/s10741-021-10135-4. Epub 2021 Jul 2.
心力衰竭的流行病学:随时间推移老年人心力衰竭和心室功能障碍的患病率。一项系统评价。
Eur J Heart Fail. 2016 Mar;18(3):242-52. doi: 10.1002/ejhf.483. Epub 2016 Jan 4.
4
Magnitude of and Prognostic Factors Associated With 1-Year Mortality After Hospital Discharge for Acute Decompensated Heart Failure Based on Ejection Fraction Findings.基于射血分数结果的急性失代偿性心力衰竭出院后1年死亡率的相关幅度及预后因素
J Am Heart Assoc. 2015 Dec 23;4(12):e002303. doi: 10.1161/JAHA.115.002303.
5
Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic Review.盐皮质激素受体拮抗剂对舒张功能障碍和射血分数保留的心力衰竭患者心脏结构和功能的影响:一项荟萃分析和系统评价
J Am Heart Assoc. 2015 Oct 12;4(10):e002137. doi: 10.1161/JAHA.115.002137.
6
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.β受体阻滞剂的使用与收缩性心力衰竭医疗保险受益人的30天全因再入院情况
Am J Med. 2015 Jul;128(7):715-21. doi: 10.1016/j.amjmed.2014.11.036. Epub 2014 Dec 30.
7
Spironolactone for heart failure with preserved ejection fraction.螺内酯治疗射血分数保留的心力衰竭。
N Engl J Med. 2014 Apr 10;370(15):1383-92. doi: 10.1056/NEJMoa1313731.
8
Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.老年射血分数保留的心力衰竭患者使用β受体阻滞剂:类别、剂量及预后
Int J Cardiol. 2014 May 15;173(3):393-401. doi: 10.1016/j.ijcard.2014.03.005. Epub 2014 Mar 11.
9
Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis.β受体阻滞剂对射血分数保留的心力衰竭的影响:一项荟萃分析。
PLoS One. 2014 Mar 5;9(3):e90555. doi: 10.1371/journal.pone.0090555. eCollection 2014.
10
SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World (SUGAR): a multi-center, retrospective, observational study.真实世界中射血分数降低型心力衰竭治疗指南依从性调查(SUGAR):一项多中心、回顾性、观察性研究。
PLoS One. 2014 Jan 27;9(1):e86596. doi: 10.1371/journal.pone.0086596. eCollection 2014.